Last reviewed · How we verify
NCT04785846: Disco-9
Registry of RESOLUTE-ONYX™ Zotarolimus-eluting Stent Utilization in Percutaneous Small Vessel Coronary Interventionism.
trial testing Percutaneous Coronary Intervention in Coronary Disease in 307 participants. Completed in 17 February 2020.
17 February 2020
Quick facts
| Lead sponsor | Fundación Investigación Sanitaria en León |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 307 |
| Start date | 18 October 2017 |
| Primary completion | 17 February 2020 |
| Estimated completion | 17 February 2020 |
| Sites | 15 locations across Spain |
Drugs / interventions tested
- Percutaneous Coronary Intervention
Conditions studied
- Coronary Disease — all drugs for Coronary Disease →
- Angina, Stable — all drugs for Angina, Stable →
- Ischemia — all drugs for Ischemia →
- Acute Coronary Syndrome — all drugs for Acute Coronary Syndrome →
Sponsor
Fundación Investigación Sanitaria en León — full company profile →
Who can join
18 and older, any sex, with Coronary Disease or Angina, Stable. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
DESIGN: Prospective, single-arm, multicenter, observational, prospective registry of the use of the RESOLUTE-ONYX™ zotarolimus-eluting stent in percutaneous coronary intervention in small vessels. Clinical follow-up at 1 month, 6 months and 1 year. OBJECTIVE: To evaluate the safety and efficacy of using RESOLUTE-ONYX zotarolimus-eluting stent in PCI in small vessels (diameter ≤2.5 mm). DISEASE UNDER STUDY: Adult patients with coronary artery disease (stable angina, silent ischemia or non-ST-segment elevation acute coronary syndrome) undergoing percutaneous coronary intervention on vessels with a diameter less than or equal to 2.5 mm. TOTAL NUMBER OF PATIENTS: Approximately 320 patients are expected to be included in the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04785846
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Percutaneous Coronary Intervention
Trials testing the same drug.
- NCT07373678 — CABG Versus PCI in Patients With Isolated LAD Chronic Total Occlusion · completed
- NCT07303439 — Randomised Trial of Dual Device Treatment Involving Drug-coated Balloon Angioplasty and Drug-eluting Stent Implantation · NA · recruiting
- NCT07034157 — A Real-World Study on Ultrasound-Based Screening and Integrated Therapeutic Strategies for Patients With Concomitant Cor · recruiting
- NCT06654453 — The Thrombus Aspiration During PCI After Thrombolysis in STEMI · NA · recruiting
- NCT06779110 — Intracoronary Optical Coherence Tomography Guidance Vs. Angiography Only Guidance for Treatment of Coronary In-stent Res · NA · recruiting
Other recruiting trials for Coronary Disease
Currently open trials in the same condition.
- NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
- NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions · NA · recruiting
- NCT06890208 — Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave · recruiting
- NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
- NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting
Other Fundación Investigación Sanitaria en León trials
Trials by the same sponsor.
- NCT03498924 — Identification and Characterization of Endometrial Cancer With Specific Tumor Markers in Serum and Endometrial Tissue · completed
- NCT03107455 — MitraClip in Acute Mitral Regurgitation · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04785846 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fundación Investigación Sanitaria en León
- Last refreshed: 10 March 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04785846.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing